Showing 4 RESULTS FOR
Innovation
In the News: Chicago Sun-Times Covers Lundbeck’s Commitment to Alzheimer’s Research and New Alzheimer’s Treatments
Lundbeck's Doug Williamson, MD, is featured in a Chicago Sun-Times article about Alzheimer's disease research and new approaches to Alzheimer's treatments.
Report Offers Hope, Outlines 537 New Drugs in Development for Neurological Disorders
A new report shows there are 537 medicines in development for neurological disorders, such as Parkinson's disease and Alzheimer's disease. Learn how Lundbeck is advancing treatments for brain disorders.
Borrowing From the Cancer Playbook to Find Treatment for Alzheimer's Disease
A CNN article highlights how researchers, including those at Lundbeck, are exploring how treatments used to battle some cancers could work against Alzheimer's disease.
New Treatments for Alzheimer's Disease are on the Horizon
By Gary Tong, MD, PhD
Advances in Alzheimer’s research are occurring faster and with greater frequency than ever before. In this Morning Consult opinion piece, Dr. Gary Tong, Lundbeck's U.S. Therapeutic Area Head for Dementia, discusses this new era of Alzheimer’s research and the promise of potential new treatments.